Logo image of ALRPD.PA

RAPID NUTRITION PLC (ALRPD.PA) Stock Fundamental Analysis

EPA:ALRPD - Euronext Paris - Matif - GB00BM9PTW47 - Common Stock - Currency: EUR

0.0076  0 (-5%)

Fundamental Rating

2

ALRPD gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 58 industry peers in the Food Products industry. Both the profitability and financial health of ALRPD have multiple concerns. ALRPD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALRPD has reported negative net income.
In the past 5 years ALRPD reported 4 times negative net income.
In the past 5 years ALRPD always reported negative operating cash flow.
ALRPD.PA Yearly Net Income VS EBIT VS OCF VS FCFALRPD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M

1.2 Ratios

ALRPD's Return On Assets of -303.92% is on the low side compared to the rest of the industry. ALRPD is outperformed by 94.83% of its industry peers.
Looking at the Return On Equity, with a value of -761.48%, ALRPD is doing worse than 91.38% of the companies in the same industry.
Industry RankSector Rank
ROA -303.92%
ROE -761.48%
ROIC N/A
ROA(3y)-313.12%
ROA(5y)-229.77%
ROE(3y)-1380.41%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALRPD.PA Yearly ROA, ROE, ROICALRPD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

ALRPD's Gross Margin of 52.57% is amongst the best of the industry. ALRPD outperforms 81.03% of its industry peers.
In the last couple of years the Gross Margin of ALRPD has declined.
The Profit Margin and Operating Margin are not available for ALRPD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.21%
GM growth 5Y-4.48%
ALRPD.PA Yearly Profit, Operating, Gross MarginsALRPD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, ALRPD has more shares outstanding
Compared to 5 years ago, ALRPD has more shares outstanding
Compared to 1 year ago, ALRPD has an improved debt to assets ratio.
ALRPD.PA Yearly Shares OutstandingALRPD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALRPD.PA Yearly Total Debt VS Total AssetsALRPD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -54.37, we must say that ALRPD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -54.37, ALRPD is doing worse than 91.38% of the companies in the same industry.
A Debt/Equity ratio of 0.21 indicates that ALRPD is not too dependend on debt financing.
ALRPD has a better Debt to Equity ratio (0.21) than 89.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z -54.37
ROIC/WACCN/A
WACCN/A
ALRPD.PA Yearly LT Debt VS Equity VS FCFALRPD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

A Current Ratio of 1.77 indicates that ALRPD should not have too much problems paying its short term obligations.
ALRPD has a Current ratio of 1.77. This is in the better half of the industry: ALRPD outperforms 68.97% of its industry peers.
ALRPD has a Quick Ratio of 1.10. This is a normal value and indicates that ALRPD is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALRPD (1.10) is better than 67.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.1
ALRPD.PA Yearly Current Assets VS Current LiabilitesALRPD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 96.71% over the past year.
Looking at the last year, ALRPD shows a very negative growth in Revenue. The Revenue has decreased by -44.60% in the last year.
The Revenue for ALRPD have been decreasing by -21.65% on average. This is quite bad
EPS 1Y (TTM)96.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.8%
Revenue 1Y (TTM)-44.6%
Revenue growth 3Y-32.65%
Revenue growth 5Y-21.65%
Sales Q2Q%-36.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
ALRPD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.70% yearly.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.21%
Revenue Next 2Y11.21%
Revenue Next 3Y11.7%
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALRPD.PA Yearly Revenue VS EstimatesALRPD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M
ALRPD.PA Yearly EPS VS EstimatesALRPD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 5 10 15 20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALRPD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALRPD.PA Price Earnings VS Forward Price EarningsALRPD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALRPD.PA Per share dataALRPD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0 -0 -0 -0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALRPD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RAPID NUTRITION PLC

EPA:ALRPD (6/27/2025, 7:00:00 PM)

0.0076

0 (-5%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-20 2025-05-20/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.10M
Analysts84.44
Price Target0.51 (6610.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.15
P/FCF N/A
P/OCF N/A
P/B 5.17
P/tB 5.17
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -303.92%
ROE -761.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.57%
FCFM N/A
ROA(3y)-313.12%
ROA(5y)-229.77%
ROE(3y)-1380.41%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.21%
GM growth 5Y-4.48%
F-ScoreN/A
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.1
Altman-Z -54.37
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.6%
Revenue growth 3Y-32.65%
Revenue growth 5Y-21.65%
Sales Q2Q%-36.18%
Revenue Next Year10.21%
Revenue Next 2Y11.21%
Revenue Next 3Y11.7%
Revenue Next 5YN/A
EBIT growth 1Y74.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year58.16%
EBIT Next 3Y42.38%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A